A comprehensive welfare scoring system for graft versus host disease clinical assessment in humanised mouse models used for pharmaceutical research.

Saved in:
Bibliographic Details
Title: A comprehensive welfare scoring system for graft versus host disease clinical assessment in humanised mouse models used for pharmaceutical research.
Authors: Nowak A; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Marlow R; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Ryan K; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Lapointe JM; Pathology, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Sutton D; Pathology, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Sharpe A; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Crook L; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Walker JA; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Little E; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Peverill J; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Holberry-Brown A; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Wassell E; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., McLaren-Jones R; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Cavanagh C; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Dobre AV; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Baker T; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Clayton M; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Karp NA; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Plugge M; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Thomas AA; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, The Discovery Centre, Cambridge, United Kingdom., Dovedi SJ; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Sitnikova SI; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom., Burrows N; Early Oncology, R&D, AstraZeneca, The Discovery Centre, Cambridge, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2025 Jun 18; Vol. 16, pp. 1617528. Date of Electronic Publication: 2025 Jun 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1617528